Pfizer says booster dose increases protection in children ages 5 to 11

A third dose of Pfizer and BioNTech’s COVID-19 vaccine produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said. Analysis of 30 participants who received a booster dose showed a 36-fold increase in neutralizing antibodies to Omicron.

Share this post:

Share on facebook
Share on twitter
Share on pinterest
Share on whatsapp
Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner